Merck
CN
  • Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.

Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2014-10-30)
V van Drongelen, E M Haisma, J J Out-Luiting, P H Nibbering, A El Ghalbzouri
摘要

Atopic dermatitis is an inflammatory skin disease that is characterized by a reduced skin barrier function, reduced filaggrin (FLG) expression as well as increased colonization by Staphylococcus aureus. This study focused on the possible involvement of FLG in epidermal colonization by S. aureus and/or whether it affects the epidermal defence mechanisms, including the expression of antimicrobial peptides (AMPs) and enzymes involved in stratum corneum barrier lipid synthesis. Furthermore, IL-31 has been shown to reduce FLG expression, but its effects on bacterial colonization and on the expression of AMPs and enzymes involved in the barrier lipid synthesis are not known. We established N/TERT-based epidermal models (NEMs), after FLG knockdown (FLG-KD) and/or cultured with IL-31, that were colonized with S. aureus for 24 h. Both FLG-KD and IL-31 supplementation resulted in significantly increased epidermal S. aureus colonization, as well as in an up-regulation of S. aureus-induced IL-8 expression. IL-31, but not FLG-KD, prevented S. aureus-induced up-regulation of mRNA expression for the AMPs human β-defensin 2 and -3 and RNAse7, whereas psoriasin expression remained unchanged. Furthermore, the S. aureus colonization induced changes in mRNA expression of ELOVL4 was not affected by FLG-KD, but was blocked by IL-31. Expression of SCD-1 and Gcase mRNA was reduced by IL-31, but not by FLG-KD. This study shows that NEMs, with FLG-KD and/or cultured in the presence of IL-31, mimic the skin of patients with atopic dermatitis in several aspects, including enhanced bacterial colonization, increased inflammatory and reduced protective responses.

材料
货号
品牌
产品描述

Sigma-Aldrich
甘油, for molecular biology, ≥99.0%
Sigma-Aldrich
甘油, ACS reagent, ≥99.5%
Sigma-Aldrich
甘油, ≥99.5%
Sigma-Aldrich
甘油, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
氯化钙 溶液, BioUltra, for molecular biology, ~1 M in H2O
Sigma-Aldrich
N-羟基丁二酰亚胺, 98%
Sigma-Aldrich
棕榈酸, ≥99%
Supelco
甘油, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
亚油酸, ≥99%
Sigma-Aldrich
氯化钙, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
Sigma-Aldrich
甘油, BioXtra, ≥99% (GC)
Sigma-Aldrich
甘油, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
甘油 溶液, 83.5-89.5% (T)
Sigma-Aldrich
甘油, meets USP testing specifications
Sigma-Aldrich
亚油酸, liquid, BioReagent, suitable for cell culture
USP
甘油, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
甘油, FCC, FG
Supelco
棕榈酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
甘油, puriss., anhydrous, 99.0-101.0% (alkalimetric)
Sigma-Aldrich
甘油, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
花生四烯酸, >95.0% (GC)
Supelco
棕榈酸, analytical standard
Sigma-Aldrich
棕榈酸, BioXtra, ≥99%
Sigma-Aldrich
氯化钙, anhydrous, powder, 99.99% trace metals basis
Sigma-Aldrich
花生四烯酸, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
甘油 溶液, puriss., meets analytical specification of Ph. Eur., BP, 84-88%
Sigma-Aldrich
亚硒酸, 98%
Supelco
亚油酸, analytical standard
Sigma-Aldrich
甘油, puriss. p.a., ACS reagent, anhydrous, dist., ≥99.5% (GC)